Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 48 min 4 sec ago

European Commission Grants Marketing Authorization for Gilead’s Zydelig(R) (Idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma

Fri, 09/19/2014 - 13:11
First-in-Class Oral Treatment for Two Incurable Blood Cancers FOSTER CITY, Calif.--(Healthcare Sales & Marketing Network)--Gilead Sciences, Inc. (GILD) today announced that the European Commission has granted marketing authorization for Zydelig® (id...
Biopharmaceuticals, Oncology, Regulatory
Gilead Sciences, Zydeli, idelalisib, chronic lymphocytic leukemia

OxySure (OXYS) Welcomes Clark Hood as Vice President, Resuscitation Sales Worldwide

Thu, 09/18/2014 - 20:26
FRISCO, TX--(Healthcare Sales & Marketing Network) - OxySure® Systems, Inc. (OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder&qu...
Devices, Personnel
OxySure Systems

Spine Wave Announces the Commercial Launch of the Annex(R) Adjacent Level System

Thu, 09/18/2014 - 17:25
The Annex(R) Adjacent Level System Allows Spine Surgeons to Utilize a Minimally Invasive Approach for the Treatment of Adjacent Level Disease SHELTON, CT--(Healthcare Sales & Marketing Network) - Spine Wave, Inc. is a medical device company dedicated to...
Devices, Orthopaedic, Neurosurgery, Product Launch
Spine Wave, Annex Adjacent Level System

Dallen Medical Announces First in Man Use of Its Compressyn(TM) Staple for Small Bone Fixation

Thu, 09/18/2014 - 16:55
SAN CLEMENTE, Calif.--(Healthcare Sales & Marketing Network)--Dallen Medical, Inc., an innovator in bone fixation and repair, today announced the first human use of its Compressyn™ Staple, the only rigid compression fixation technology that delivers contin...
Devices, Orthopaedic
Dallen Medical, Compressyn, bone fixation

TriVascular, Inc. to Initiate Voluntary Field Safety Corrective Action for Certain Ovation Prime(R) Aortic Stent Grafts

Thu, 09/18/2014 - 16:53
SANTA ROSA, Calif., Sept. 18, 2014 -- (Healthcare Sales & Marketing Network) -- TriVascular Technologies, Inc. (TRIV), today announces it will initiate a voluntary field safety corrective action related to certain of its 29 mm Ovation Prime aortic stent gr...
Devices, Interventional, Product Recall
TriVascular Technologies, aortic stent graft

K2M Debuts EVEREST Minimally Invasive Spinal System at the Society for Minimally Invasive Spinal Surgery Global Forum 2014

Thu, 09/18/2014 - 16:50
LEESBURG, Va., Sept. 18, 2014 -- (Healthcare Sales & Marketing Network) -- K2M Group Holdings, Inc. (KTWO) (the "Company" or "K2M), a global medical device company focused on designing, developing and commercializing innovative and proprieta...
Devices, Orthopaedic, Neurosurgery, Product Launch
K2M, EVEREST, Minimally Invasive Spinal System, pedicle screw

Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development

Thu, 09/18/2014 - 16:47
Drug Development Team Now Complete and Fully Focused on Clinical Trial Implementation NEW YORK, Sept. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Relmada Therapeutics, Inc., (RLMD), a clinical-stage company developing novel therapies for the ...
Biopharmaceuticals, Personnel
Relmada Therapeutics

Covidien Sonicision(TM) Portfolio Expansion Enables Surgeons to Choose Ideal Cordless Ultrasonic Dissection Device for Each Patient and Procedure

Thu, 09/18/2014 - 16:44
Commitment to delivering innovative medical technologies creates most versatile cordless ultrasonic offering in the industry DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV) today announced the expansion of its Sonicision™ Co...
Devices, Surgery, Product Launch
Covidien, Sonicision, Ultrasonic Dissection Device

World’s First Integrated Delivery System Meets All Endpoints in the Direct II Randomized, Controlled Drug-Eluting Coronary Stent Study

Thu, 09/18/2014 - 16:42
WASHINGTON, D.C.--(Healthcare Sales & Marketing Network)--Svelte Medical Systems today reported that its drug-eluting coronary stent Integrated Delivery System (IDS), a new approach to Percutaneous Coronary Intervention (PCI) and the first advance in coron...
Devices, Interventional Cardiology
Svelte Medical Systems, coronary stent, drug eluting stent

Milestone Scientific Receives CE Mark Approval for Epidural Injection System

Thu, 09/18/2014 - 16:39
LIVINGSTON, NJ--(Healthcare Sales & Marketing Network) - Milestone Scientific Inc. (MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that its subsidia...
Devices, Surgery, Regulatory
Milestone Scientific, CompuFlo, Epidural, Anesthesia

Baxano Surgical to Explore Strategic Alternatives for Its MIS Spine Business

Thu, 09/18/2014 - 16:35
RALEIGH, N.C., Sept. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Baxano Surgical, Inc. (BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spin...
Devices, Orthopaedic, Neurosurgery
Baxano Surgical

Medrobotics Announces Launch of the Flex(R) Retractor

Thu, 09/18/2014 - 16:33
Uniquely Adjustable Retractor Brings Exceptional Surgical Exposure and Efficiency to Transoral Robotic and Laser Microsurgery Procedures RAYNHAM, Mass.--(Healthcare Sales & Marketing Network)--Medrobotics Corp., a surgical products company with core com...
Devices, Surgery, Product Launch
Medrobotics, Flex Retractor, robotic surgery

Trevena Appoints Adam M. Koppel to the Board of Directors

Thu, 09/18/2014 - 16:30
KING OF PRUSSIA, Pa.--(Healthcare Sales & Marketing Network)--Trevena, Inc. (TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Adam M. Koppel...
Biopharmaceuticals, Personnel
Trevena, GPCR, G protein coupled receptor

Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits

Thu, 09/18/2014 - 16:28
The world's first and only dual therapy stent WASHINGTON, Sept. 18, 2014 -- (Healthcare Sales & Marketing Network) --Prof. Stephen W.L. Lee presented two-year optical coherence tomography (OCT) findings and three-year clinical follow up from the EGO CO...
Devices, Interventional Cardiology
OrbusNeich, Dual Therapy Stent, drug eluting stent

NOXXON Pharma Expands Management Team by Appointing Don Munoz as Chief Financial Officer

Thu, 09/18/2014 - 16:24
Appointment initiates a US presence in the Boston area BERLIN & BOSTON--(Healthcare Sales & Marketing Network)--NOXXON Pharma has appointed Don Munoz to the newly created position of Chief Financial Officer. Mr. Munoz will strengthen the executive manag...
Biopharmaceuticals, Personnel
NOXXON Pharma, Spiegelmers

Evotec Takes Legal Steps Against Andromeda Biotech, Ltd.

Thu, 09/18/2014 - 16:21
HAMBURG, Germany, Sept. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Evotec AG (EVT.F) (TecDAX) (ISIN:DE0005664809) announced today after careful evaluation that it will take legal steps against Israel-based Andromeda Biotech, Ltd. ("Andromed...
Biopharmaceuticals, Litigation
Evotec, Andromeda Biotech, DiaPep277

Integra LifeSciences to Acquire Medtronic's MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines

Wed, 09/17/2014 - 12:58
PLAINSBORO, N.J., Sept. 17, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) and Medtronic, Inc. today announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and l...
Devices, Acquisitions
Integra LifeSciences, Medtronic, MicroFrance, Xomed

Ivera Medical Files Patent Infringement Case Against Catheter Connections and CTI for Sales of Light Blue DualCap IV Pole Strips

Wed, 09/17/2014 - 12:50
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical announced that it has filed a new patent infringement case against Catheter Connections and its Ohio-based distributor, Clinical Technology Inc., based on sales of their Light Blue DualC...
Devices, Litigation
Ivera Medical, Catheter Connections, Curos Strip

CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI(R)

Wed, 09/17/2014 - 12:36
Total Deal Valued at up to Approximately $133.5 Million; Approximately $18.1 million Upfront CTI Retains 100% Commercialization Rights to PIXUVRI in U.S. and Certain E.U. Territories Conference Call Scheduled for Today at 8:30 a.m. EDT SEATTLE, S...
Biopharmaceuticals, Oncology, Licensing
CTI BioPharma, Servier, PIXUVRI, pixantrone, B-cell NHL

Boston Scientific Receives CE Mark For The Vercise(TM) Deep Brain Stimulation (DBS) System For Treating Patients With Tremor

Wed, 09/17/2014 - 12:26
Vercise DBS System is the First DBS System Offering Precise Neural Targeting and a 25-Year Battery Life MARLBOROUGH, Mass., Sept. 17, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) has received CE Mark for the Ver...
Devices, Neurosurgery, Regulatory
Boston Scientific, Vercise, Deep Brain Stimulation, essential tremor

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong